Primary aldosteronism is a highly prevalent and severely under-diagnosed syndrome that contributes to cardiovascular and kidney disease that can be mitigated with targeted therapies. This webinar will review major updates in our understanding of this syndrome, its diagnosis, and optimal treatment.
During this webinar, the speakers will review:
1) New concepts in the pathogenesis of the primary aldosteronism syndrome.
2) The prevalence and under-recognition of the primary aldosteronism syndrome.
3) Updated approaches to diagnosing primary aldosteronism.
4) Optimal and pragmatic approaches to treating primary aldosteronism.